Skip to content

Conventional Versus Automated Measurement of Blood Pressure in the Office (The CAMBO Study)

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00325832
Acronym
CAMBO
Enrollment
750
Registered
2006-05-15
Start date
2006-01-31
Completion date
Unknown
Last updated
2010-08-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

Hypertension, Blood Pressure, Systolic Pressure, Diastolic Pressure, Blood Pressure Monitoring, Ambulatory

Brief summary

To determine if the use of automated office blood pressure readings can improve management of systolic hypertension in routine clinical practice. Automated office SBP recordings in routine clinical practice using the BpTRU device will reflect more accurately the mean awake ambulatory systolic BP than will manual BP readings taken with conventional mercury sphygmomanometry. This should lead to improvements in the management of systolic hypertension with optimization of drug therapy in practices using the BpTRU device.

Interventions

DEVICEBpTRU
DEVICEConventional mercury sphygmomanometry

Sponsors

Heart and Stroke Foundation of Ontario
CollaboratorOTHER
Sunnybrook Health Sciences Centre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Both treated and untreated patients with systolic hypertension under routine FP care * For untreated patients, routine office SBP as measured by the patient's FP at the last routine office visit using a mercury device must have SBP ≥ 160 mmHg and DBP \<= 95 mmHg * For patients already receiving antihypertensive therapy, the last routine office BP as measured by the patient's FP using mercury sphygmomanometry must be SBP ≥ 140 mmHg and DBP \<= 90 mmHg

Exclusion criteria

* Presence of target organ damage such as MI, stroke, and serum creatinine twice normal * Diabetes mellitus treated with insulin or oral hypoglycemic therapy * Secondary hypertension * Participation in another research study involving measurement of BP * Patient's insistence on using self BP measurement outside of the study * Any conditions or circumstances which might preclude the successful completion of the study

Design outcomes

Primary

MeasureTime frame
ambulatory blood pressure

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026